| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |